Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercepharma.com
FiercePharma
Get the latest updates from FiercePharma directly as they happen.
Follow now 387 followers
Latest posts
Last updated 37 minutes ago
Beyond the AI hype: How life sciences can turn agents into a competitive advantage
37 minutes ago
Salesforce’s Mark Sullivan explains why trust, data discipline and human oversight will...
Lilly touts promise of Zepbound-Taltz combo in patients with obesity and psoriatic arthritis
about 2 hours ago
As evidence of tirzepatide’s efficacy mounts across a range of cardiometabolic conditions...
InflaRx to prune headcount by 30%, curb COVID drug spending in bid to advance new favorite asset izicopan
about 5 hours ago
Shortly after floating a contingency plan for its asset, vilobelimab—which boasts an...
Vanda's shares drop after 2nd FDA rejection for Hetlioz in jet lag disorder
about 5 hours ago
In a saga that has spread over seven years, the FDA has...
AZ taps Spain head Rick Suarez to lead US biopharma unit, head up $50B investment surge
about 6 hours ago
Suarez will return to the U.S. as SVP and president, head of...
As biosim industry confronts looming 'void,' 2026 marks a chance to take stock and embrace changing landscape
about 7 hours ago
With the ten-year anniversary of the first approved biosimilar in the rearview...
Acuitas takes majority stake in Montreal-based RNA construct manufacturer
about 7 hours ago
Acuitas Therapeutics shelled out an undisclosed sum to acquire a majority stake...
Novo Nordisk conducts a new conversation on weight stigma at major NYC commuter hub
about 9 hours ago
Novo Nordisk has begun a vital year for its weight-loss franchise with...
Gilead study finds HIV can evolve to resist lenacapavir, but doing so hampers the virus’ replication
1 day ago
Though Gilead Sciences made waves last June with a landmark FDA approval...
FDA untitled letter skewers Esperion’s claims about cholesterol med Nexlizet in TV ad
1 day ago
The FDA is apparently not charmed by the mischievous “Lipid Lurkers” in...
Viking enlists commercial chief to battle obesity giants, while Aspen names CCO to prep for Parkinson's launch
1 day ago
Viking Therapeutics and Aspen Neuroscience have both stepped up their commercialization planning...
Daiichi taps Genesis to handle commercialization of leukemia med Vanflyta in 13 European countries
1 day ago
Under the agreement, Genesis is responsible for marketing Daiichi's 2023-approved acute myeloid...